Mounjaro, a recently approved therapy from a pharmaceutical firm , is generating significant excitement within the medical world. This injectable medication acts in a distinct way, impacting multiple receptors involved in blood sugar control : GIP and GLP-1. Early research suggest it may provide impressive benefits in A1C , conceivably even greater